facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation

ORPHA: 466950

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation, sourced from HPO and Orphanet clinical annotations.

Atypical behaviorIntellectual disabilityMild intellectual disabilityGlobal developmental delayMotor delayAbnormal facial shapeSquare faceStrabismusAbnormality of visionAnxietyDelayed speech and language developmentNeonatal hypotoniaConstipationAbnormality of the respiratory systemSleep disturbanceAttention deficit hyperactivity disorderPelvic kidneyWide mouthThin upper lip vermilionEpicanthusHypertelorismBroad foreheadPosteriorly rotated earsHearing impairmentProminent antihelixBulbous noseWide nasal bridgeBroad nasal tipDeeply set eyeAbnormality of refractionVisual lossThick eyebrowLong palpebral fissureSynophrysAggressive behaviorAutistic behaviorSingle transverse palmar creaseHirsutismBrachydactylyProminent fingertip padsDysarthriaAbsent speechObesityPes planusTruncal obesityDysphagiaGastroesophageal refluxBilateral tonic-clonic seizureAsthmaVentriculomegalyRecurrent respiratory infectionsAbnormal pattern of respirationInverted nipplesShort palmDepressed nasal bridgeAbnormal nostril morphologyPes valgusBranchial anomalyTypical absence seizureSimple febrile seizureProminent foreheadBroad chinBorderline personality disorderWidened subarachnoid spaceNasogastric tube feedingDilatation of renal calicesArachnoid cystSelf-injurious behavior

Classification & Codes

Orphanet Code

ORPHA:466950
facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation
OrphanetORPHA:466950
Treatments0 drug(s)
Symptoms on record68 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation | OrphanDrug